Macasasa, Rogelio P.

HRN: 29-17-40  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2026
CO-AMOXICLAV 625MG (TAB)
06/20/2026
06/26/2026
ORAL
625mg
Tid
Uti
Remove - Pending Acceptance
06/20/2026
CO-AMOXICLAV 625MG (TAB)
06/20/2026
06/26/2026
ORAL
625mg
Tid
Uti
Remove - Pending Acceptance
06/22/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/22/2026
06/29/2026
IV
600mg
Q8
Abscess Anterior Chest
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: